Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Aurothioglucose
Cat. No.:
OB0425LY-256
Appearance:
Solid
Purity:
96.1%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Aurothioglucose is a potent active-site TrxR1 inhibitor containing monovalent gold ion.
Synonyms:
12192-57-3; Gold thioglucose; Aurothioglucose hydrate; Solganal; Gold(1+),(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxane-2-thiolate;
CAS No.:
12192-57-3
Compound CID:
454937
Formula:
C6H11AuO5S
Formula Weight:
392.18
Specification
Target:
NF-κB; HIV; Reactive oxygen species
Pathway:
NF-κB; Anti-infection; Immunology/Inflammation; Metabolic enzyme/Protease
Solubility:
DMSO, Water
Storage:
Storage at -20°C.
Applications:
Aurothioglucose can be used for cell cycle regulation and apoptosis-related pathway studies.
